[1]
D. D. Gadade, S. S. Pekamwar, and M. D. Shirsat, “CRYSTAL ENGINEERING OF ANTIVIRAL AGENT EFAVIRENZ FOR SOLUBILITY ENHANCEMENT”, J. Drug Delivery Ther., vol. 8, no. 1, pp. 86–91, Jan. 2018, doi: 10.22270/jddt.v8i1.1637.